Zhejiang Medicine マネジメント

マネジメント基準チェック /34

Zhejiang Medicineの CEO はChun Lei Luで、 Jun2018年に任命され、の在任期間は 6.42年です。は、会社の株式の0.035%を直接所有しており、その価値はCN¥ 5.39M 。経営陣と取締役会の平均在任期間はそれぞれ3.4年と3.4年です。

主要情報

Chun Lei Lu

最高経営責任者

CN¥2.8m

報酬総額

CEO給与比率	n/a
CEO在任期間	6.4yrs
CEOの所有権	0.04%
経営陣の平均在職期間	3.4yrs
取締役会の平均在任期間	3.4yrs

経営陣の近況

Recent updates

CEO（最高経営責任者

Chun Lei Lu (57 yo)

6.4yrs

在職期間

CN¥2,844,200

報酬

Mr. Chun Lei Lu is President and Director of Zhejiang Medicine Co., Ltd. since June 15, 2018. He serves as Vice Chairman of Zhejiang Medicine Co., Ltd.since June 16, 2021. Mr. Lu was Executive Vice Presid...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Chun Lei Lu	President & Vice Chairman	6.4yrs	CN¥2.84m	0.035% CN¥ 5.4m
Hongwei Wang	Executive Vice President	6.4yrs	CN¥2.61m	0.019% CN¥ 3.0m
Huan Ming Yu	Vice President	9.4yrs	CN¥2.05m	0.042% CN¥ 6.3m
Jianhong Ping	Vice President	3.4yrs	CN¥1.90m	0.0052% CN¥ 793.1k
Yongbin An	Senior Manager	3.4yrs	CN¥2.24m	データなし
Liping Liang	Senior Manager	3.4yrs	CN¥1.97m	0.0078% CN¥ 1.2m
Xiaoping Wang	Senior Manager	3.4yrs	CN¥2.10m	0.0052% CN¥ 793.1k
Nan Xing Li	Vice Chairman & Vice President	6.4yrs	CN¥2.86m	0.12% CN¥ 17.7m
Qirong Li	CFO & Financial Director	3.4yrs	CN¥1.22m	0.0052% CN¥ 793.1k
Guangshan Guo	Accounting Supervisor	no data	データなし	データなし
Minzhi Shao	Board Secretary	1.2yrs	データなし	データなし
Jin Lin Zhu	Vice President	9.4yrs	CN¥1.82m	0.036% CN¥ 5.6m

3.4yrs

平均在職期間

50yo

平均年齢

経験豊富な経営陣: 600216の経営陣は経験豊富であると考えられます ( 3.4年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Chun Lei Lu	President & Vice Chairman	12.4yrs	CN¥2.84m	0.035% CN¥ 5.4m
Nan Xing Li	Vice Chairman & Vice President	6.4yrs	CN¥2.86m	0.12% CN¥ 17.7m
Chun Bo Li	Chairman of the Board	21.4yrs	CN¥3.46m	0.0097% CN¥ 1.5m
Naiwei Chen	Independent Director	6.4yrs	CN¥120.00k	データなし
Yizheng Qiu	Independent Director	3.4yrs	CN¥120.00k	データなし
Zhenhua Chu	Director	3.4yrs	CN¥1.86m	0.0078% CN¥ 1.2m
Yuqing Yu	Director	3.4yrs	CN¥1.85m	0.0052% CN¥ 793.1k
Qing Xia	Independent Director	3.4yrs	CN¥120.00k	データなし
Xiaoming Wu	Independent Director	2.9yrs	CN¥120.00k	データなし
Zhong Liu	Vice Chairman	1.4yrs	データなし	データなし
Yiyuan Wu	Chief Supervisor	1.4yrs	データなし	データなし
Hongyu Cang	Director	1.4yrs	データなし	データなし

3.4yrs

平均在職期間

48.5yo

平均年齢

経験豊富なボード: 600216の取締役会は経験豊富であると考えられます ( 3.4年の平均在任期間)。

Zhejiang Medicine マネジメント

マネジメント 基準チェック /34

主要情報

経営陣の近況

Zhejiang Medicine Co., Ltd., Annual General Meeting, Jun 18, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.55 (vs CN¥0.029 in 3Q 2023)

Investor sentiment improves as stock rises 20%

Zhejiang Medicine Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024

Second quarter 2024 earnings released: EPS: CN¥0.23 (vs CN¥0.16 in 2Q 2023)

New minor risk - Share price stability

Investor sentiment improves as stock rises 19%

Dividend reduced to CN¥0.15

Zhejiang Medicine Co., Ltd. to Report First Half, 2024 Results on Aug 23, 2024

Zhejiang Medicine Co., Ltd., Annual General Meeting, Jun 18, 2024

First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.12 in 1Q 2023)

Zhejiang Medicine Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Investor sentiment improves as stock rises 18%

Zhejiang Medicine Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024

New minor risk - Earnings quality

Third quarter 2023 earnings released: EPS: CN¥0.029 (vs CN¥0.10 in 3Q 2022)

Zhejiang Medicine Co., Ltd. to Report Q3, 2023 Results on Oct 26, 2023

Second quarter 2023 earnings released: EPS: CN¥0.16 (vs CN¥0.14 in 2Q 2022)

Zhejiang Medicine Co., Ltd. to Report First Half, 2023 Results on Aug 24, 2023

First quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.27 in 1Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.10 (vs CN¥0.25 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.25 in 2Q 2021)

Less than half of directors are independent

Third quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.20 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.30 in 2Q 2020)

Investor sentiment deteriorated over the past week

Full year 2020 earnings released: EPS CN¥0.75 (vs CN¥0.36 in FY 2019)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: CN¥15.25

New 90-day low: CN¥12.75

New 90-day low: CN¥13.19

Third quarter earnings released

Third quarter earnings released

New 90-day low: CN¥14.55

Zhejiang Medicine Co., Ltd. to Report Q3, 2020 Results on Oct 23, 2020

New 90-day low: CN¥15.44

New 90-day low - CN¥16.73

First half earnings released

Earnings released

Zhejiang Medicine Co., Ltd. to Report First Half, 2020 Results on Aug 26, 2020

CEO（最高経営責任者

在職期間

報酬

リーダーシップ・チーム

平均在職期間

平均年齢

取締役

平均在職期間

平均年齢

マネジメント基準チェック /34